Trecento: in silico network-driven identification of target combinations for combination therapy
暂无分享,去创建一个
[1] Read OnlineThe,et al. The Biology of Cancer , 2022, Nature.
[2] Hans-Georg Müller,et al. Functional Data Analysis , 2016 .
[3] S. Zohar,et al. Competing designs for drug combination in phase I dose‐finding clinical trials , 2015, Statistics in medicine.
[4] Sourav S. Bhowmick,et al. One feature doesn't fit all: characterizing topological features of targets in signaling networks , 2014, BCB.
[5] Michael J. MacDonald,et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase , 2014, Nature.
[6] Fan Wang,et al. The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma , 2014, PloS one.
[7] Neil O. Carragher,et al. Quantitative phenotypic and pathway profiling guides rational drug combination strategies , 2014, Front. Pharmacol..
[8] Joon Young Choi,et al. Synergistic Anti-Cancer Effect of Phenformin and Oxamate , 2014, PloS one.
[9] S. Mandrekar. Dose-finding trial designs for combination therapies in oncology. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Ramanathan,et al. Network‐Based Approaches in Drug Discovery and Early Development , 2013, Clinical pharmacology and therapeutics.
[11] Ali Masoudi-Nejad,et al. Drug-target and disease networks: polypharmacology in the post-genomic era , 2013, In Silico Pharmacology.
[12] B. Al-Lazikani,et al. Drugging cancer genomes , 2013, Nature Reviews Drug Discovery.
[13] Judith A. Blake,et al. The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse , 2013, Nucleic Acids Res..
[14] Shang-Yi Huang,et al. Novel AKT Inhibitor Afuresertib In Combination With Bortezomib and Dexamethasone Demonstrates Favorable Safety Profile and Significant Clinical Activity In Patients With Relapsed/Refractory Multiple Myeloma , 2013 .
[15] J. Luban,et al. Overcoming current limitations in humanized mouse research. , 2013, The Journal of infectious diseases.
[16] Orla Mulhern,et al. Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice. , 2013, The Journal of infectious diseases.
[17] Tina Eliassi-Rad,et al. Which Network Similarity Measure Should You Choose: An Empirical Study , 2013 .
[18] Jie Li,et al. Characterization of regulatory features of housekeeping and tissue-specific regulators within tissue regulatory networks , 2013, BMC Systems Biology.
[19] Mona Singh,et al. Simple Topological Features Reflect Dynamics and Modularity in Protein Interaction Networks , 2013, PLoS Comput. Biol..
[20] Albert-László Barabási,et al. Universality in network dynamics , 2013, Nature Physics.
[21] Önder Gürcan,et al. An Emergent Model for Mimicking Human Neuronal Pathways in Silico , 2013, ECAL.
[22] Tao Xu,et al. Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways , 2013, PLoS Comput. Biol..
[23] H. Wen,et al. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms , 2013, Pharmaceutical development and technology.
[24] Hongwei Liang,et al. The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells , 2013, Molecular Cancer.
[25] Rong Xu,et al. Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing , 2013, BMC Bioinformatics.
[26] Christian Drosten,et al. Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.
[27] Mario Albrecht,et al. NetworkPrioritizer: a versatile tool for network-based prioritization of candidate disease genes or other molecules , 2013, Bioinform..
[28] Alexander E. Ivliev,et al. Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach , 2013, PloS one.
[29] Isidro Cortes-Ciriano,et al. Experimental validation of in silico target predictions on synergistic protein targets , 2013, Journal of Cheminformatics.
[30] Riccardo Bellazzi,et al. Network-based target ranking for polypharmacological therapies , 2013, J. Biomed. Informatics.
[31] Casey S. Greene,et al. Functional Knowledge Transfer for High-accuracy Prediction of Under-studied Biological Processes , 2013, PLoS Comput. Biol..
[32] Walter A. Kosters,et al. Computing the Eccentricity Distribution of Large Graphs , 2013, Algorithms.
[33] M. Bogyo,et al. Target deconvolution techniques in modern phenotypic profiling. , 2013, Current opinion in chemical biology.
[34] Xiaohui Lin,et al. A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[35] A. Guekht,et al. Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action , 2012, Journal of the Neurological Sciences.
[36] Ruth Nussinov,et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.
[37] Sergio Contrino,et al. InterMine: a flexible data warehouse system for the integration and analysis of heterogeneous biological data , 2012, Bioinform..
[38] Danai Koutra,et al. NetSimile: A Scalable Approach to Size-Independent Network Similarity , 2012, ArXiv.
[39] Yoshihiro Yamanishi,et al. Relating drug–protein interaction network with drug side effects , 2012, Bioinform..
[40] Matthew S. Creamer,et al. Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling , 2012, BMC Systems Biology.
[41] I. Jurisica,et al. Network-based characterization of drug-regulated genes, drug targets, and toxicity. , 2012, Methods.
[42] Igor Goryanin,et al. Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 network , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[43] Erik De Schutter,et al. A Stochastic Signaling Network Mediates the Probabilistic Induction of Cerebellar Long-Term Depression , 2012, The Journal of Neuroscience.
[44] Y. Moreau,et al. Computational tools for prioritizing candidate genes: boosting disease gene discovery , 2012, Nature Reviews Genetics.
[45] A. Mitra,et al. Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products , 2012, The AAPS Journal.
[46] I. Cree,et al. Targeting EGFR and PI3K pathways in ovarian cancer , 2012, British Journal of Cancer.
[47] Shaojie Qiao,et al. Importance Evaluation of Individuals in Online Social Networks Based on Fuzzy AHP Algorithm , 2012 .
[48] Virginia Vassilevska Williams,et al. Multiplying matrices faster than coppersmith-winograd , 2012, STOC '12.
[49] Elhanan Borenstein,et al. Computational systems biology and in silico modeling of the human microbiome , 2012, Briefings Bioinform..
[50] S. Arold,et al. Noise in cellular signaling pathways: causes and effects. , 2012, Trends in biochemical sciences.
[51] Courtney Corley,et al. Topological analysis of protein co-abundance networks identifies novel host targets important for HCV infection and pathogenesis , 2012, BMC Systems Biology.
[52] J. Kotz,et al. Phenotypic screening, take two , 2012 .
[53] Jeremy S Logue,et al. Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. , 2012, Genes & development.
[54] An Pan,et al. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review , 2012, BMJ : British Medical Journal.
[55] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[56] B. Viollet,et al. Cellular and molecular mechanisms of metformin: an overview. , 2012, Clinical science.
[57] A. Shelling,et al. In Vivo Testing of MicroRNA-Mediated Gene Knockdown in Zebrafish , 2012, Journal of biomedicine & biotechnology.
[58] Mamoru Ito,et al. Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.
[59] Chong-Jing Zhang,et al. Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. , 2012, Journal of the American Chemical Society.
[60] Sourav S. Bhowmick,et al. PANI: an interactive data-driven tool for target prioritization in signaling networks , 2012, IHI '12.
[61] David Olmos,et al. First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] Ranadip Pal,et al. A Kinase Inhibition Map Approach for Tumor Sensitivity Prediction and Combination Therapy Design for Targeted Drugs , 2011, Pacific Symposium on Biocomputing.
[63] Jimeng Sun,et al. Centralities in Large Networks: Algorithms and Observations , 2011, SDM.
[64] R. Bast,et al. Molecular approaches to personalizing management of ovarian cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[65] John O'Quigley,et al. Continual Reassessment Method for Partial Ordering , 2011, Biometrics.
[66] Nicola J. Mulder,et al. Generation and Analysis of Large-Scale Data-Driven Mycobacterium tuberculosis Functional Networks for Drug Target Identification , 2011, Adv. Bioinformatics.
[67] C. Arteaga. The phosphatidylinositol-3 kinase/mTOR pathway: new agents , 2011, Breast Cancer Research.
[68] Gang Feng,et al. Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..
[69] T. Mizushima,et al. Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis , 2011, PloS one.
[70] T. Spiro,et al. Pulmonary toxicities of tyrosine kinase inhibitors. , 2011, Clinical advances in hematology & oncology : H&O.
[71] R. Tallarida,et al. Quantitative methods for assessing drug synergism. , 2011, Genes & cancer.
[72] Shao Q Yao,et al. Proteome profiling reveals potential cellular targets of staurosporine using a clickable cell-permeable probe. , 2011, Chemical communications.
[73] Andreas Hoppe,et al. Metannogen: annotation of biological reaction networks , 2011, Bioinform..
[74] Kuo-Chen Chou,et al. Docking and molecular dynamics simulations of peroxisome proliferator activated receptors interacting with pan agonist sodelglitazar. , 2011, Protein and peptide letters.
[75] M. Cloutier,et al. Dynamic modeling and analysis of cancer cellular network motifs. , 2011, Integrative biology : quantitative biosciences from nano to macro.
[76] Shou-De Lin,et al. Cost-Sensitive Multi-Label Learning for Audio Tag Annotation and Retrieval , 2011, IEEE Transactions on Multimedia.
[77] Santiago Ramón-García,et al. Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen , 2011, Antimicrobial Agents and Chemotherapy.
[78] Reinhard Schneider,et al. Using graph theory to analyze biological networks , 2011, BioData Mining.
[79] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[80] Joel Lexchin,et al. The cost of drug development: a systematic review. , 2011, Health policy.
[81] D. Pe’er,et al. Principles and Strategies for Developing Network Models in Cancer , 2011, Cell.
[82] T. Spicer,et al. Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors , 2011, Proceedings of the National Academy of Sciences.
[83] Bolin Ding,et al. Fast Set Intersection in Memory , 2011, Proc. VLDB Endow..
[84] Lokesh P. Tripathi,et al. TargetMine, an Integrated Data Warehouse for Candidate Gene Prioritisation and Target Discovery , 2011, PloS one.
[85] Luis G Valerio,et al. In silico toxicology models and databases as FDA Critical Path Initiative toolkits , 2011, Human Genomics.
[86] Alan Ashworth,et al. Searching for synthetic lethality in cancer. , 2011, Current opinion in genetics & development.
[87] Z. Paroush,et al. Substrate-dependent control of MAPK phosphorylation in vivo , 2011, Molecular systems biology.
[88] Giancarlo Troncone,et al. The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. , 2010, Endocrine-related cancer.
[89] Fengxi Song,et al. Feature Selection Using Principal Component Analysis , 2010, 2010 International Conference on System Science, Engineering Design and Manufacturing Informatization.
[90] Kara Dolinski,et al. The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..
[91] Channing J Der,et al. TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling , 2010, Journal of molecular signaling.
[92] A. Casadevall,et al. Reproducible Science , 2010, Infection and Immunity.
[93] Yiling Lu,et al. Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. , 2010, Cancer research.
[94] S. Dulchavsky,et al. Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells. , 2010, Anticancer research.
[95] M. Bogyo,et al. Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes. , 2010, Chemistry & biology.
[96] Tsviya Olender,et al. GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.
[97] David S. Roos,et al. Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach , 2010, PLoS neglected tropical diseases.
[98] Ramon Gonzalez,et al. Metabolic Analysis of Wild-type Escherichia coli and a Pyruvate Dehydrogenase Complex (PDHC)-deficient Derivative Reveals the Role of PDHC in the Fermentative Metabolism of Glucose* , 2010, The Journal of Biological Chemistry.
[99] Sergei Maslov,et al. Protein abundances and interactions coevolve to promote functional complexes while suppressing non-specific binding , 2010, 1007.2668.
[100] Jeffrey R. Wang,et al. Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer. , 2010, International journal of oncology.
[101] K. Flaherty,et al. Safety and efficacy results from the first-in-human study of the oral MEK 1/2 inhibitor GSK1120212. , 2010 .
[102] R. Turner,et al. Eigenvector Centrality Mapping for Analyzing Connectivity Patterns in fMRI Data of the Human Brain , 2010, PloS one.
[103] Jian-Hua Tong,et al. Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML , 2010, Science.
[104] Ross S Hall,et al. Drug target prediction and prioritization: using orthology to predict essentiality in parasite genomes , 2010, BMC Genomics.
[105] D. Greiner,et al. Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.
[106] Benjamin Markman,et al. Status of PI3K inhibition and biomarker development in cancer therapeutics. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[107] Benjamin A. Ellingson,et al. Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..
[108] Judith B. Zaugg,et al. Bacterial adaptation through distributed sensing of metabolic fluxes , 2010, Molecular systems biology.
[109] George Haughn,et al. Reverse genetics techniques: engineering loss and gain of gene function in plants. , 2010, Briefings in functional genomics.
[110] J. Engelman,et al. The PI3K pathway as drug target in human cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[111] R. Abraham,et al. Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor. , 2010, Journal of medicinal chemistry.
[112] Sylvain Meloche,et al. From basic research to clinical development of MEK1/2 inhibitors for cancer therapy , 2010, Journal of hematology & oncology.
[113] N. Poulter,et al. Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis , 2010, Hypertension.
[114] R. Brereton,et al. Support vector machines for classification and regression. , 2010, The Analyst.
[115] Leon Fogelfeld,et al. Tagatose: from a sweetener to a new diabetic medication? , 2010, Expert opinion on investigational drugs.
[116] Gary D Bader,et al. NetPath: a public resource of curated signal transduction pathways , 2010, Genome Biology.
[117] Laurie G. Hudson,et al. Targeting the EGF Receptor for Ovarian Cancer Therapy , 2009, Journal of oncology.
[118] H. Verheul,et al. Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? , 2009, Angiogenesis.
[119] J. Post,et al. ERK Nuclear Translocation Is Dimerization-independent but Controlled by the Rate of Phosphorylation*♦ , 2009, The Journal of Biological Chemistry.
[120] Uri Keich,et al. Reliability and efficiency of algorithms for computing the significance of the Mann–Whitney test , 2009, Comput. Stat..
[121] Zhe Zhang,et al. Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study , 2009, BMC medicine.
[122] Patricia Amara,et al. Structure–function relationships of anaerobic gas-processing metalloenzymes , 2009, Nature.
[123] Thierry Emonet,et al. Understanding Modularity in Molecular Networks Requires Dynamics , 2009, Science Signaling.
[124] Eszter Bohus,et al. Cluster analysis statistical spectroscopy using nuclear magnetic resonance generated metabolic data sets from perturbed biological systems. , 2009, Analytical chemistry.
[125] Guohua Wang,et al. Reconstruct gene regulatory network using slice pattern model , 2009, BMC Genomics.
[126] V. Grantcharova,et al. Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis , 2009, Science Signaling.
[127] John S. Rumsfeld,et al. Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.
[128] P. Aloy,et al. A network medicine approach to human disease , 2009, FEBS letters.
[129] J. Medina-Franco,et al. Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1 , 2009, ChemMedChem.
[130] Steffen Klamt,et al. Hypergraphs and Cellular Networks , 2009, PLoS Comput. Biol..
[131] Vasyl Pihur,et al. RankAggreg, an R package for weighted rank aggregation , 2009, BMC Bioinformatics.
[132] Yanqing Zhang,et al. SVMs Modeling for Highly Imbalanced Classification , 2009, IEEE Transactions on Systems, Man, and Cybernetics, Part B (Cybernetics).
[133] Laura M. Heiser,et al. Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. , 2009, Cancer research.
[134] E. Giralt,et al. Knitting and untying the protein network: Modulation of protein ensembles as a therapeutic strategy , 2008, Protein science : a publication of the Protein Society.
[135] M. Fukumoto,et al. KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer , 2008, British Journal of Cancer.
[136] Foster Provost,et al. Machine Learning from Imbalanced Data Sets 101 , 2008 .
[137] L. Lai,et al. Finding multiple target optimal intervention in disease-related molecular network , 2008, Molecular systems biology.
[138] O. Kuchaiev,et al. Topological network alignment uncovers biological function and phylogeny , 2008, Journal of The Royal Society Interface.
[139] Gongping Yang,et al. On the Class Imbalance Problem , 2008, 2008 Fourth International Conference on Natural Computation.
[140] Allen D. Roses,et al. Pharmacogenetics in drug discovery and development: a translational perspective , 2008, Nature Reviews Drug Discovery.
[141] Bonnie Berger,et al. Global alignment of multiple protein interaction networks with application to functional orthology detection , 2008, Proceedings of the National Academy of Sciences.
[142] Kwang-Hyun Cho,et al. Coherent coupling of feedback loops: a design principle of cell signaling networks , 2008, Bioinform..
[143] Jian Huang,et al. Penalized feature selection and classification in bioinformatics , 2008, Briefings Bioinform..
[144] Aidong Zhang,et al. Bridging centrality: graph mining from element level to group level , 2008, KDD.
[145] Luay Nakhleh,et al. Rapidly exploring structural and dynamic properties of signaling networks using PathwayOracle , 2008, BMC Systems Biology.
[146] Zhike Zi,et al. SBML-SAT: a systems biology markup language (SBML) based sensitivity analysis tool , 2008, BMC Bioinformatics.
[147] Andreas Christmann,et al. Support vector machines , 2008, Data Mining and Knowledge Discovery Handbook.
[148] Yan Gao,et al. Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Epithelial Ovarian Cancer , 2008, Molecular Cancer Research.
[149] S. P. Ivy,et al. Cediranib (AZD2171) is an active agent in recurrent epithelial ovarian cancer , 2008 .
[150] F. Schreiber,et al. Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks , 2008, Gene regulation and systems biology.
[151] Øyvind Drivenes,et al. Treatment with small interfering RNA affects the microRNA pathway and causes unspecific defects in zebrafish embryos , 2008, The FEBS journal.
[152] Dario Rossi,et al. Support vector regression for link load prediction , 2008, 2008 4th International Telecommunication Networking Workshop on QoS in Multiservice IP Networks.
[153] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[154] R. Sun,et al. Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.
[155] Michael Hucka,et al. LibSBML: an API Library for SBML , 2008, Bioinform..
[156] Jacob D. Feala,et al. Search Algorithms as a Framework for the Optimization of Drug Combinations , 2008, PLoS Comput. Biol..
[157] Ron Bose,et al. Mechanism of activation and inhibition of the HER4/ErbB4 kinase. , 2008, Structure.
[158] N. Nachar. The Mann-Whitney U: A Test for Assessing Whether Two Independent Samples Come from the Same Distribution , 2008 .
[159] Tijana Milenkoviæ,et al. Uncovering Biological Network Function via Graphlet Degree Signatures , 2008, Cancer informatics.
[160] N. Barkai,et al. Variability and robustness in biomolecular systems. , 2007, Molecular cell.
[161] Yang Wang,et al. Cost-sensitive boosting for classification of imbalanced data , 2007, Pattern Recognit..
[162] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[163] Jean-Marc Schwartz,et al. A global view of drug-therapy interactions , 2007, BMC pharmacology.
[164] Xiaowei Zhuang,et al. Kinetic analysis of sequential multistep reactions. , 2007, The journal of physical chemistry. B.
[165] Jiguo Cao,et al. Parameter estimation for differential equations: a generalized smoothing approach , 2007 .
[166] Kristiina Vuori,et al. The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures , 2007, Molecular Cancer Therapeutics.
[167] Man Lung Yiu,et al. Efficient top-k aggregation of ranked inputs , 2007, TODS.
[168] G. King,et al. The role of protein kinase C activation in diabetic nephropathy. , 2007, Kidney international. Supplement.
[169] M. Blagosklonny,et al. Antagonistic drug combinations that select against drug resistance: From bacteria to cancer , 2007, Cancer biology & therapy.
[170] Ulf Leser,et al. Fast and practical indexing and querying of very large graphs , 2007, SIGMOD '07.
[171] Patrick L. Harrington,et al. Selective Control of the Apoptosis Signaling Network in Heterogeneous Cell Populations , 2007, PloS one.
[172] John M. Hancock,et al. A kinetic core model of the glucose-stimulated insulin secretion network of pancreatic β cells , 2007, Mammalian Genome.
[173] C. Der,et al. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.
[174] Vivienne Marsh,et al. Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor , 2007, Clinical Cancer Research.
[175] David S Mendelson,et al. Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[176] Quan-guang Zhang,et al. Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury , 2007, FEBS letters.
[177] Ravi Iyengar,et al. Compartment-specific feedback loop and regulated trafficking can result in sustained activation of Ras at the Golgi. , 2007, Biophysical journal.
[178] Li Wang,et al. CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data , 2007, Bioinform..
[179] G. Fagiolo. Clustering in complex directed networks. , 2006, Physical review. E, Statistical, nonlinear, and soft matter physics.
[180] H. Herzel,et al. UniHI: an entry gate to the human protein interactome , 2006, Nucleic Acids Res..
[181] Mudita Singhal,et al. Simulation of Biochemical Networks using Copasi - A Complex Pathway Simulator , 2006, Proceedings of the 2006 Winter Simulation Conference.
[182] N. Riel. Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments , 2006, Briefings Bioinform..
[183] D. Lauffenburger,et al. Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.
[184] G. Wray,et al. Endo16 is required for gastrulation in the sea urchin Lytechinus variegatus , 2006, Development, growth & differentiation.
[185] R. Shoemaker. The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.
[186] Ting-Chao Chou,et al. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.
[187] R. Copeland,et al. Drug–target residence time and its implications for lead optimization , 2006, Nature Reviews Drug Discovery.
[188] S. Wilhelm,et al. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. , 2006, Seminars in oncology.
[189] Victor S. Sheng,et al. Thresholding for Making Classifiers Cost-sensitive , 2006, AAAI.
[190] Vincent Conitzer,et al. Improved Bounds for Computing Kemeny Rankings , 2006, AAAI.
[191] Chun-Nan Hsu,et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization , 2006, Nucleic Acids Res..
[192] Jesse Davis,et al. The relationship between Precision-Recall and ROC curves , 2006, ICML.
[193] C. Johnston,et al. Vinegar: medicinal uses and antiglycemic effect. , 2006, MedGenMed : Medscape general medicine.
[194] Jianzhi Zhang,et al. Why Do Hubs Tend to Be Essential in Protein Networks? , 2006, PLoS genetics.
[195] Samiul Hasan,et al. Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis , 2006, PLoS Comput. Biol..
[196] Julie Morris,et al. Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo , 2006, Breast Cancer Research.
[197] Philip S. Yu,et al. Dual Labeling: Answering Graph Reachability Queries in Constant Time , 2006, 22nd International Conference on Data Engineering (ICDE'06).
[198] Chris F. Taylor,et al. The MGED Ontology: a resource for semantics-based description of microarray experiments , 2006, Bioinform..
[199] D-M Hu,et al. Time-dependent sensitivity analysis of biological networks: coupled MAPK and PI3K signal transduction pathways. , 2006, The journal of physical chemistry. A.
[200] Jacky L. Snoep,et al. BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems , 2005, Nucleic Acids Res..
[201] Ivor W. Tsang,et al. Core Vector Machines: Fast SVM Training on Very Large Data Sets , 2005, J. Mach. Learn. Res..
[202] R. Albert. Scale-free networks in cell biology , 2005, Journal of Cell Science.
[203] Jaime Prat,et al. Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[204] Li Chen,et al. Stack-based Algorithms for Pattern Matching on DAGs , 2005, VLDB.
[205] B. Brandt,et al. The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches. , 2005, Histology and histopathology.
[206] Alan J Wolfe,et al. Glucose metabolism at high density growth of E. coli B and E. coli K: differences in metabolic pathways are responsible for efficient glucose utilization in E. coli B as determined by microarrays and Northern blot analyses. , 2005, Biotechnology and bioengineering.
[207] D. Verbanac,et al. Combined in silico and in vitro approach to drug screening , 2005 .
[208] Tao Jiang,et al. MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[209] Jenny Bangham,et al. Therapeutics: Cetuximab constricts conformational contortionist , 2005, Nature Reviews Cancer.
[210] U. Sauer,et al. Impact of Global Transcriptional Regulation by ArcA, ArcB, Cra, Crp, Cya, Fnr, and Mlc on Glucose Catabolism in Escherichia coli , 2005, Journal of bacteriology.
[211] P. Postma,et al. Reducing the glucose uptake rate in Escherichia coli affects growth rate but not protein production. , 2005, Biotechnology and bioengineering.
[212] Zixiang Xiong,et al. Optimal number of features as a function of sample size for various classification rules , 2005, Bioinform..
[213] R P Araujo,et al. A mathematical model of combination therapy using the EGFR signaling network. , 2005, Bio Systems.
[214] L. Solnica-Krezel. Conserved Patterns of Cell Movements during Vertebrate Gastrulation , 2005, Current Biology.
[215] Tian-Li Wang,et al. Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. , 2005, Cancer research.
[216] I. Y. Kim,et al. Adaptive weighted-sum method for bi-objective optimization: Pareto front generation , 2005 .
[217] F. Sams-Dodd. Target-based drug discovery: is something wrong? , 2005, Drug discovery today.
[218] Péter Csermely,et al. The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.
[219] J. Au,et al. Evaluation of Combination Chemotherapy , 2004, Clinical Cancer Research.
[220] Holger Sondermann,et al. Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless , 2004, Cell.
[221] Hao Chen,et al. Content-rich biological network constructed by mining PubMed abstracts , 2004, BMC Bioinformatics.
[222] Rosemary Steinmetz,et al. Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. , 2004, Molecular endocrinology.
[223] Stephen Kwek,et al. Applying Support Vector Machines to Imbalanced Datasets , 2004, ECML.
[224] Bernhard Schölkopf,et al. A tutorial on support vector regression , 2004, Stat. Comput..
[225] Kai Wang,et al. A non‐parametric approach to the design and analysis of two‐dimensional dose‐finding trials , 2004, Statistics in medicine.
[226] K. Shimizu,et al. Metabolic regulation analysis of icd-gene knockout Escherichia coli based on 2D electrophoresis with MALDI-TOF mass spectrometry and enzyme activity measurements , 2004, Applied Microbiology and Biotechnology.
[227] Michael Koutsilieris,et al. The Akt pathway: molecular targets for anti-cancer drug development. , 2004, Current cancer drug targets.
[228] Joseph Shiloach,et al. Transcription levels of key metabolic genes are the cause for different glucose utilization pathways in E. coli B (BL21) and E. coli K (JM109). , 2004, Journal of biotechnology.
[229] T. McShane,et al. Development and Use of Biomarkers in Oncology Drug Development , 2004, Toxicologic pathology.
[230] John Langford,et al. Cost-sensitive learning by cost-proportionate example weighting , 2003, Third IEEE International Conference on Data Mining.
[231] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[232] Malcolm S. Mitchell,et al. Combinations of anticancer drugs and immunotherapy , 2003, Cancer Immunology, Immunotherapy.
[233] Huan Liu,et al. Feature Selection for High-Dimensional Data: A Fast Correlation-Based Filter Solution , 2003, ICML.
[234] A. Brodie. Aromatase inhibitor development and hormone therapy: a perspective. , 2003, Seminars in oncology.
[235] S. Kimura,et al. A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. , 2003, The Biochemical journal.
[236] Jun'ichi Tsujii,et al. GENIA corpus - a semantically annotated corpus for bio-textmining , 2003, ISMB.
[237] Marketa Zvelebil,et al. Phosphoinositide 3-kinase signalling--which way to target? , 2003, Trends in pharmacological sciences.
[238] J. Lehár,et al. Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[239] J. Grandis,et al. Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2 , 2003, Oncogene.
[240] Obi L. Griffith,et al. The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.
[241] Annabel E. Todd,et al. Target Selection and Determination of Function in Structural Genomics , 2003, IUBMB life.
[242] G. Carpenter,et al. ErbB-4: mechanism of action and biology. , 2003, Experimental cell research.
[243] N. Normanno,et al. Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. , 2003, Endocrine-related cancer.
[244] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[245] Joseph Schlessinger,et al. Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor , 2002, Cell.
[246] Hyeran Byun,et al. Applications of Support Vector Machines for Pattern Recognition: A Survey , 2002, SVM.
[247] Jean Girard,et al. Effects of benfluorex on fatty acid and glucose metabolism in isolated rat hepatocytes: from metabolic fluxes to gene expression. , 2002, Diabetes.
[248] B. Kreider,et al. Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. , 2002, Chemistry & biology.
[249] Sayan Mukherjee,et al. Choosing Multiple Parameters for Support Vector Machines , 2002, Machine Learning.
[250] Liang Qiao,et al. Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. , 2002, Frontiers in bioscience : a journal and virtual library.
[251] M E J Newman,et al. Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[252] Kathy Chen,et al. Network dynamics and cell physiology , 2001, Nature Reviews Molecular Cell Biology.
[253] T Li,et al. Performance of batch membrane reactor: Glycerol-3-phosphate synthesis coupled with adenosine triphosphate regeneration. , 2001, Biotechnology and bioengineering.
[254] A. Adjei,et al. Blocking oncogenic Ras signaling for cancer therapy. , 2001, Journal of the National Cancer Institute.
[255] G Asselin,et al. Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. , 2001, American journal of physiology. Endocrinology and metabolism.
[256] J. Thomas,et al. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. , 2001, Genome research.
[257] Phillip Bonacich,et al. Eigenvector-like measures of centrality for asymmetric relations , 2001, Soc. Networks.
[258] George M. Church,et al. Aligning gene expression time series with time warping algorithms , 2001, Bioinform..
[259] U. Brandes. A faster algorithm for betweenness centrality , 2001 .
[260] J. Suykens. Nonlinear modelling and support vector machines , 2001, IMTC 2001. Proceedings of the 18th IEEE Instrumentation and Measurement Technology Conference. Rediscovering Measurement in the Age of Informatics (Cat. No.01CH 37188).
[261] Moni Naor,et al. Rank aggregation methods for the Web , 2001, WWW '01.
[262] I. Sobola,et al. Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates , 2001 .
[263] S. Ellner,et al. Crossing the hopf bifurcation in a live predator-prey system. , 2000, Science.
[264] J. Maxa,et al. Drug Interactions Due to Cytochrome P450 , 2000, Proceedings.
[265] S. Ekker,et al. Effective targeted gene ‘knockdown’ in zebrafish , 2000, Nature Genetics.
[266] Nello Cristianini,et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..
[267] Rainer Schrader,et al. A Note on the Finite Time Behavior of Simulated Annealing , 2000, Math. Oper. Res..
[268] Monilola A. Olayioye,et al. The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.
[269] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[270] J. Nemunaitis,et al. A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[271] Chris N. Potts,et al. Constraint satisfaction problems: Algorithms and applications , 1999, Eur. J. Oper. Res..
[272] Jae-Gu Pan,et al. Acetate Metabolism in a pta Mutant ofEscherichia coli W3110: Importance of Maintaining Acetyl Coenzyme A Flux for Growth and Survival , 1999, Journal of bacteriology.
[273] Carmen Bambach,et al. Drawing and Painting in the Italian Renaissance Workshop: Theory and Practice, 1300–1600 , 1999 .
[274] Pedro M. Domingos. MetaCost: a general method for making classifiers cost-sensitive , 1999, KDD '99.
[275] Si Wu,et al. Improving support vector machine classifiers by modifying kernel functions , 1999, Neural Networks.
[276] B. Hemmings,et al. Regulation of protein kinase cascades by protein phosphatase 2A. , 1999, Trends in biochemical sciences.
[277] U. Bhalla,et al. Emergent properties of networks of biological signaling pathways. , 1999, Science.
[278] Advances in Kernel Methods , 1998 .
[279] J L Sussman,et al. Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. , 1998, Acta crystallographica. Section D, Biological crystallography.
[280] Kai Ming Ting,et al. Inducing Cost-Sensitive Trees via Instance Weighting , 1998, PKDD.
[281] R. C. Williamson,et al. Support vector regression with automatic accuracy control. , 1998 .
[282] Duncan J. Watts,et al. Collective dynamics of ‘small-world’ networks , 1998, Nature.
[283] Christopher J. C. Burges,et al. A Tutorial on Support Vector Machines for Pattern Recognition , 1998, Data Mining and Knowledge Discovery.
[284] Massimiliano Pontil,et al. Support Vector Machines for 3D Object Recognition , 1998, IEEE Trans. Pattern Anal. Mach. Intell..
[285] J. Shiloach,et al. Proposed mechanism of acetate accumulation in two recombinant Escherichia coli strains during high density fermentation. , 1998, Biotechnology and bioengineering.
[286] Nir Friedman,et al. Bayesian Network Classifiers , 1997, Machine Learning.
[287] W. R. Farmer,et al. Reduction of aerobic acetate production by Escherichia coli , 1997, Applied and environmental microbiology.
[288] Markus Schulze,et al. Morphologie, Syntax und Semantik im Rahmen der linksassoziativen Grammatik , 1997, GLDV-Jahrestagung.
[289] John Bell,et al. A review of methods for the assessment of prediction errors in conservation presence/absence models , 1997, Environmental Conservation.
[290] Lothar Thiele,et al. A Comparison of Selection Schemes Used in Evolutionary Algorithms , 1996, Evolutionary Computation.
[291] Luís Torgo,et al. Regression by Classification , 1996, SBIA.
[292] D. Saari,et al. The Copeland method , 1996 .
[293] Ron Kohavi,et al. A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.
[294] Bart Selman,et al. Systematic Versus Stochastic Constraint Satisfaction , 1995, IJCAI.
[295] S. Shapiro,et al. Mathematics without Numbers , 1993 .
[296] G. Castañeda-Hernández,et al. Analgesic effects of combinations containing opioid drugs with either aspirin or acetaminophen in the rat , 1993 .
[297] David A. Landgrebe,et al. A survey of decision tree classifier methodology , 1991, IEEE Trans. Syst. Man Cybern..
[298] Lawrence A Leiter,et al. Cellular Mechanism of Action of Metformin , 1990, Diabetes Care.
[299] Joost Engelfriet,et al. A Comparison of Boundary Graph Grammars and Context-Free Hypergraph Grammars , 1990, Inf. Comput..
[300] L. Darrell Whitley,et al. The GENITOR Algorithm and Selection Pressure: Why Rank-Based Allocation of Reproductive Trials is Best , 1989, ICGA.
[301] Carlo Gaibisso,et al. A Partially Persistent Data Structure for the Set-Union Problem with Backtracking , 1988, IMYCS.
[302] Kishor S. Trivedi,et al. Numerical transient analysis of markov models , 1988, Comput. Oper. Res..
[303] J. Azuma,et al. Mechanism of direct cardiostimulating actions of hydralazine. , 1987, European journal of pharmacology.
[304] P. Waage,et al. Studies concerning affinity , 1986 .
[305] Robert E. Tarjan,et al. Fibonacci heaps and their uses in improved network optimization algorithms , 1984, JACM.
[306] W. L. Chiou,et al. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve , 1978, Journal of Pharmacokinetics and Biopharmaceutics.
[307] Teofilo F. Gonzalez,et al. An Efficient Algorithm for the Kolmogorov-Smirnov and Lilliefors Tests , 1977, TOMS.
[308] M. Stephens. EDF Statistics for Goodness of Fit and Some Comparisons , 1974 .
[309] Robert E. Tarjan,et al. Depth-First Search and Linear Graph Algorithms , 1972, SIAM J. Comput..
[310] Peter C. Fishburn,et al. Letter to the Editor - Additive Utilities with Incomplete Product Sets: Application to Priorities and Assignments , 1967, Oper. Res..
[311] Edsger W. Dijkstra,et al. A note on two problems in connexion with graphs , 1959, Numerische Mathematik.
[312] H. B. Mann,et al. On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .
[313] P. Jaccard. THE DISTRIBUTION OF THE FLORA IN THE ALPINE ZONE.1 , 1912 .
[314] Natasa Przulj. Biological. , 1895, The journals of gerontology. Series A, Biological sciences and medical sciences.
[315] S. Ratsimamanga,et al. SODIUM OXAMATE FOR THE TREATMENT OF DABETC CONDITIONS , 2017 .
[316] Anna M. Ritz,et al. Signaling hypergraphs. , 2014, Trends in biotechnology.
[317] Américo Pereira,et al. Review of feature selection techniques in bioinformatics , 2012 .
[318] Ritika,et al. Formulation Tactics for the Delivery of Poorly Soluble Drugs , 2012 .
[319] R. Tiwari,et al. Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.
[320] M. Kemal Sönmez,et al. Computing graphlet signatures of network nodes and motifs in Cytoscape with GraphletCounter , 2012, Bioinform..
[321] R. N. Mishra,et al. Jiao Gu Lan (Gynostemma pentaphyllum): The Chinese Rasayan- Current Research Scenario , 2011 .
[322] M. Erion,et al. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes. , 2011, Handbook of experimental pharmacology.
[323] Xiang-Sun Zhang,et al. Drug Target Identification Based on Flux Balance Analysis of Metabolic Networks , 2010 .
[324] S. Giordano,et al. ReviewMolecular mechanisms of acquired resistance to tyrosine kinase targeted therapy , 2010 .
[325] Mona Singh,et al. Toward the dynamic interactome: it's about time , 2010, Briefings Bioinform..
[326] Edda Klipp,et al. Monte Carlo analysis of an ODE Model of the Sea Urchin Endomesoderm Network Supplementary Table 1: Differential Equations , 2009 .
[327] Chih-Jen Lin,et al. A Practical Guide to Support Vector Classication , 2008 .
[328] Tom Fawcett,et al. ROC Graphs: Notes and Practical Considerations for Researchers , 2007 .
[329] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[330] Johannes Grotendorst,et al. Classification of Highly Unbalanced CYP450 Data of Drugs Using Cost Sensitive Machine Learning Techniques , 2007, J. Chem. Inf. Model..
[331] T. Maiwald,et al. An error model for protein quantification , 2007, Bioinform..
[332] R. Thadhani,et al. Formal trials versus observational studies , 2006 .
[333] Lorin Roskos,et al. From XenoMouse® Technology to Panitumumab (ABX-EGF) , 2005 .
[334] Padhraic Smyth,et al. Analysis and Visualization of Network Data using JUNG , 2005 .
[335] Seth Love,et al. Apoptotic pathways as targets for novel therapies in cancer and other diseases , 2005 .
[336] Pablo A. Iglesias,et al. Dynamic Properties of Network Motifs Contribute to Biological Network , 2005 .
[337] Stan Salvador,et al. FastDTW: Toward Accurate Dynamic Time Warping in Linear Time and Space , 2004 .
[338] Boleslaw K. Szymanski,et al. Taming the Curse of Dimensionality in Kernels and Novelty Detection , 2004, WSC.
[339] Sheldon Howard Jacobson,et al. The Theory and Practice of Simulated Annealing , 2003, Handbook of Metaheuristics.
[340] Mark A. Hall,et al. Correlation-based Feature Selection for Machine Learning , 2003 .
[341] Tomasz Winiarski,et al. Feature Selection Based on Information Theory Filters , 2003 .
[342] Yanli Wang,et al. MMDB: Entrez's 3D-structure database , 2003, Nucleic Acids Res..
[343] B. Druker,et al. STI571: a paradigm of new agents for cancer therapeutics. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[344] A. Bhuyan,et al. Resting membrane potential as a marker of apoptosis: studies on Xenopus oocytes microinjected with cytochrome c , 2001, Cell Death and Differentiation.
[345] X. F. Zhang,et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. , 2001, Recent progress in hormone research.
[346] D. Lauffenburger,et al. A Computational Study of Feedback Effects on Signal Dynamics in a Mitogen‐Activated Protein Kinase (MAPK) Pathway Model , 2001, Biotechnology progress.
[347] Eamonn J. Keogh,et al. Derivative Dynamic Time Warping , 2001, SDM.
[348] Joshua Alspector,et al. SVM-based Filtering of E-mail Spam with Content-specic Misclassication Costs , 2001 .
[349] Samy Bengio,et al. SVMTorch: Support Vector Machines for Large-Scale Regression Problems , 2001, J. Mach. Learn. Res..
[350] Klaus Obermayer,et al. Support vector learning for ordinal regression , 1999 .
[351] N. Emanuele,et al. Consequences of Alcohol Use in Diabetics , 1998, Alcohol health and research world.
[352] M. Debono,et al. Antibiotics that inhibit fungal cell wall development. , 1994, Annual review of microbiology.
[353] S. Wasserman,et al. Social Network Analysis: Methods and Applications , 1994 .
[354] William L. Goffe,et al. Global Optimization of Statistical Functions with Simulated Annealing , 1994 .
[355] K. Reinhardt. Sorting In-Place with a Worst Case Complexity of n log n − 1 . 3 n + O ( log n ) Comparisons and ε n log n + O ( 1 ) Transports ∗ , 1992 .
[356] Stanley Lemeshow,et al. Applied Logistic Regression, Second Edition , 1989 .
[357] Lorenz T. Biegler,et al. Nonlinear parameter estimation: A case study comparison , 1986 .
[358] H. Bock,et al. Recent Advances in Parameteridentification Techniques for O.D.E. , 1983 .
[359] L. Freeman. Centrality in social networks conceptual clarification , 1978 .
[360] R. Graham,et al. Spearman's Footrule as a Measure of Disarray , 1977 .
[361] V. Vapnik. Pattern recognition using generalized portrait method , 1963 .
[362] Thomas Marill,et al. On the effectiveness of receptors in recognition systems , 1963, IEEE Trans. Inf. Theory.
[363] A. A. Lumsdaine,et al. The American soldier: Combat and its aftermath. (Studies in social psychology in World War II), Vol. 2 , 1949 .
[364] P.-C.-F. Daunou,et al. Mémoire sur les élections au scrutin , 1803 .
[365] Torsten Schaub,et al. Under Consideration for Publication in Theory and Practice of Logic Programming Minimal Intervention Strategies in Logical Signaling Networks with Asp , 2022 .